跳至正文
研究论文

The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes.

Liu Yunlong, Liu Junyi, Ma Yan, Zhang Yongyong, Chen Qiong, Yang Xin, Shang Yanchun · 共同作者

Bioengineered2022; 13(1): 1802--1813

DOI
10.1080/21655979.2021.1997090
PMID
35012432

摘要

关键词 · IL-29, Olmesartan, Osteoarthritis, extracellular matrix

Osteoarthritis (OA) is a cartilage degenerative disease commonly observed in the elderly population and is pathologically characterized by the degradation of the cartilage extracellular matrix (ECM). Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) are critical enzymes involved in the degradation of ECM. Olmesartan is an inhibitor of the angiotensin II receptor developed for the treatment of hypertension, and recent studies show that it exerts anti-inflammatory effects in arthritis. The present study aimed to investigate the mechanism of the protective effect of Olmesartan on cartilage ECM degradation. Interleukin-29 (IL-29) is a novel inflammatory mediator involved in the inflammation and degradation of cartilage in OA, and human T/C-28a2 cells treated with it were the inflammatory model in vitro. We found that the degradation of type 2 collagens and aggrecans was induced by IL-29, accompanied by the upregulation of MMPs and ADAMTSs, but the presence of Olmesartan significantly ameliorated these increases. In addition, Olmesartan abolished IL-29- induced oxidative stress and elevated the expression level of TNF receptor-associated factor 6 (TRAF-6). Mechanistically, we showed that Olmesartan suppressed IL-29- caused inhibitor kappa B alpha (IkappaBalpha) expression and nuclear translocation of nuclear factor kappa-B (NF-kappaB) p65, indicating it suppressed the activation of the NF-kappaB pathway. Collectively, our data reveal that Olmesartan exerted a protective function on IL-29- induced type 2 collagen degradation in human chondrocytes.

陈琼发布于 225 字约 2 分钟阅读浏览量加载中…

留言板

欢迎留下与本页内容相关的问题、建议或想法。

正在读取留言…

审核通过后,昵称和留言将公开显示。请勿填写私人联系方式。

← 返回论文列表